PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Year Ending	Current	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019
Market Capitalization	17	51	48	44	38	48
Market Cap Growth	-65.14%	5.50%	10.67%	16.31%	-21.44%	-15.56%
Enterprise Value	-44	-17	-37	41	37	47
PE Ratio	-	-11.80	-11.39	-12.28	-9.80	-11.74
PB Ratio	0.54	0.70	0.54	6.53	7.37	9.47
P/FCF Ratio	-8.96	-13.43	-11.73	-13.10	-16.04	-16.59
P/OCF Ratio	-8.96	-13.43	-11.73	-13.10	-16.04	-16.59
EV/EBITDA Ratio	37.17	3.96	8.76	-11.67	-9.59	-11.61
EV/EBIT Ratio	37.17	3.96	8.76	-11.67	-9.59	-11.61
EV/FCF Ratio	20.10	4.51	9.02	-12.44	-15.69	-16.41
Debt / Equity Ratio	-	-	-	-	0.01	-
Debt / EBITDA Ratio	-	-	-	-	-0.02	-
Debt / FCF Ratio	-	-	-	-	-0.03	-
Quick Ratio	8.12	115.99	121.24	3.04	0.87	0.69
Current Ratio	8.16	116.18	121.38	3.14	1.01	0.88
Interest Coverage	-	-	-8327.41	-1164.87	-8446.88	-
Return on Equity (ROE)	-25.10%	-5.40%	-6.10%	-49.30%	-80.80%	-73.90%
Return on Assets (ROA)	-15.20%	-5.40%	-6.00%	-44.30%	-68.20%	-65.70%
Return on Capital (ROIC)	-19.47%	-8.88%	-4.88%	-54.24%	-74.10%	-81.37%
Earnings Yield	-67.39%	-8.47%	-8.78%	-8.14%	-10.20%	-8.52%
FCF Yield	-12.34%	-7.45%	-8.53%	-7.64%	-6.23%	-6.03%
Buyback Yield / Dilution	54.69%	-25.56%	-971.73%	-60.24%	-23.24%	-13.57%
Total Shareholder Return	54.69%	-25.56%	-971.73%	-60.24%	-23.24%	-13.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).